Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models (Q39413387)
Jump to navigation
Jump to search
scientific article published on 11 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models |
scientific article published on 11 January 2012 |
Statements
1 reference
Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models (English)
1 reference
Joseph M Gozgit
1 reference
Matthew J Wong
1 reference
Lauren Moran
1 reference
Scott Wardwell
1 reference
Qurish K Mohemmad
1 reference
Narayana I Narasimhan
1 reference
William C Shakespeare
1 reference
Frank Wang
1 reference
Tim Clackson
1 reference
Victor M Rivera
1 reference
11 January 2012
1 reference
1 reference
Identifiers
1 reference